RABIES

This early-stage study tested two new vaccines, one for yellow fever and one for rabies, in 112 healthy adults aged 18 to 40. The main goal was to check safety and see how well the vaccines trigger an immune response. Researchers gave different doses to find the best balance of s…

This study tested the safety of a new rabies vaccine in 80 healthy people aged 10 to 60. Participants received the vaccine using one of two different schedules (Essen or Zagreb). Researchers monitored for side effects for up to 6 months. The goal was to see if the vaccine is safe…

This study tested a new rabies vaccine (VRVg) in 1,708 healthy children and adults in Thailand. The goal was to see if it works as well as current vaccines in preventing rabies before exposure. Participants received up to three doses, and some got a booster shot later to check lo…

This study tested a new medicine called SYN023 to prevent rabies in people who were bitten or scratched by animals like dogs or bats. About 448 adults at different risk levels received either SYN023 or the standard rabies shot, along with a rabies vaccine. The goal was to see if …

This study surveyed 214 Egyptian doctors to see how well they follow official guidelines for preventing rabies after an animal bite. Researchers used 10 real-life scenarios to test doctors' knowledge and calculate a score. The goal was to find gaps in care and estimate the health…